INVESTOR INFORMATION

 

Annual Reports Subsidiaries 

PROV FOODS PRIVATE LIMITED

• FY 22-23

• FY 21-22

• FY 20-21

• FY 19-20

PROVENTUS RETAIL PRIVATE LIMITED

• FY 22-23

• FY 21-22

• FY 20-21

• FY 19-20

PROV-NOVA BIO TECHNOLOGIES PRIVATE LIMITED

• FY 22-23

• FY 21-22

• FY 20-21

PROVENTUS COMMODITIES DMCC

• FY 21-22

 Reconciliation of share capital audit report.(ROSCAR)

• December 23

• September 23

INC 27

• INC 27

  • • Mr. Ranganathan Subramanian (Chairman, Independent Director) | DIN: 00125493

    • Mr. Durga Prasad Jhawar (Managing Director and CEO) | DIN: 02005091

    • Mrs. Sweta Jain (Independent Director) | DIN: 07241949

    • Mrs. Swati Jhawar (Non-Executive Director) | DIN: 06446297

    • Mr. Deepak Agrawal (Whole Time Director) | DIN: 07362004

    • Mr. Shalin Khanna (Whole Time Director) | DIN: 06734684

  • AUDIT COMMITTEE

    • Mr. Ranganathan Subramanian (Chairman)

    • Mr. Durga Prasad Jhawar

    • Mrs. Sweta Jain

    NOMINATION AND REMUNERATION COMMITTEE

    • Mr. Ranganathan Subramanian (Chairman)

    • Mrs. Sweta Jain

    • Mrs. Swati Jhawar

    STAKEHOLDERS RELATIONSHIP COMMITTEE

    • Mr. Ranganathan Subramanian (Chairman)

    • Mr. Deepak Agrawal

    • Mr. Shalin Khanna

    CORPORATE SOCIAL RESPONSIBILITY COMMITTEE

    • Mr. Durga Prasad Jhawar (Chairman)

    • Mr. Ranganathan Subramanian

    • Mr. Deepak Agrawal

    • Mr. Shalin Khanna

  • Terms of Reference of Audit Committee-

    1. oversight of financial reporting process and the disclosure of financial information relating to our Company to ensure that the financial statements are correct, sufficient and credible;

    2. recommendation for appointment, re-appointment, replacement, remuneration and terms of appointment of auditors, including the internal auditor, cost auditor and statutory auditor of our Company and the fixation of the audit fee;

    3. approval of payment to statutory auditors for any other services rendered by the statutory auditors;

    4. formulation of a policy on related party transactions, which shall include materiality of related party transactions;

    5. reviewing, at least on a quarterly basis, the details of related party transactions entered into by our Company pursuant to each of the omnibus approvals given;

    6. examining and reviewing, with the management, the annual financial statements and auditor's report thereon before submission to the Board for approval, with particular reference to:

    a) Matters required to be included in the director’s responsibility statement to be included in the Board’s report in terms of clause (c) of sub-section 3 of section 134 of the Companies Act, 2013;

    b) Changes, if any, in accounting policies and practices and reasons for the same;

    c) Major accounting entries involving estimates based on the exercise of judgment by management;

    d) Significant adjustments made in the financial statements arising out of audit findings;

    e) Compliance with listing and other legal requirements relating to financial statements;

    f) Disclosure of any related party transactions; and

    g) Modified opinion(s) in the draft audit report.

    7. reviewing, with the management, the quarterly, half-yearly and annual financial statements before submission to the Board for approval;

    8. reviewing, with the management, the statement of uses / application of funds raised through an issue (public issue, rights issue, preferential issue, etc.), the statement of funds utilized for purposes other than those stated in the offer document / prospectus / notice and the report submitted by the monitoring agency monitoring the utilisation of proceeds of a public or rights issue, and making appropriate recommendations to the Board to take up steps in this matter;

    9. reviewing and monitoring the auditor’s independence and performance, and effectiveness of audit process;

    10. approval of any subsequent modification of transactions of our Company with related parties and omnibus approval for related party transactions proposed to be entered into by our Company, subject to the conditions as may be prescribed;

    11. approval of related party transaction to which the subsidiary is a party;

    12. scrutiny of inter-corporate loans and investments;

    13. valuation of undertakings or assets of our Company, wherever it is necessary;

    14. evaluation of internal financial controls and risk management systems;

    15. reviewing, with the management, performance of statutory and internal auditors, adequacy of the internal control systems;

    16. reviewing the adequacy of internal audit function, if any, including the structure of the internal audit department, staffing and seniority of the official heading the department, reporting structure coverage and frequency of internal audit;

    17. discussion with internal auditors of any significant findings and follow up there on;

    18. reviewing the findings of any internal investigations by the internal auditors into matters where there is suspected fraud or irregularity or a failure of internal control systems of a material nature and reporting the matter to the Board;

    19. discussion with statutory auditors before the audit commences, about the nature and scope of audit as well as post-audit discussion to ascertain any area of concern;

    20. recommending to the Board the appointment and removal of the external auditor, fixation of audit fees and approval for payment for any other services;

    21. looking into the reasons for substantial defaults in the payment to depositors, debenture holders, shareholders (in case of non-payment of declared dividends) and creditors;

    22. reviewing the functioning of the whistle blower mechanism;

    23. monitoring the end use of funds raised through public offers and related matters;

    24. overseeing the vigil mechanism established by our Company, with the chairman of the Audit Committee directly hearing grievances of victimization of employees and directors, who used vigil mechanism to report genuine concerns in appropriate and exceptional cases;

    25. approval of appointment of chief financial officer (i.e., the whole-time finance director or any other person heading the finance function or discharging that function) after assessing the qualifications, experience and background, etc. of the candidate;

    26. reviewing the utilization of loans and/or advances from/investment by the holding company in the subsidiary exceeding ₹ 1,500 lakhs or 10% of the asset size of the subsidiary, whichever is lower including existing loans / advances / investments existing as on the date of coming into force of this provision;

    27. to formulate, review and make recommendations to the Board to amend the terms of reference of the Audit Committee from time to time;

    28. consider and comment on rationale, cost-benefits and impact of schemes involving merger, demerger, amalgamation etc., on our Company and its shareholders; and

    29. carrying out any other functions required to be carried out by the Audit Committee as contained in the SEBI Listing Regulations, Companies Act, 2013, uniform listing agreements and/or any other applicable law, as and when amended from time to time.

    The Audit Committee shall mandatorily review the following information:

    1. Management discussion and analysis of financial condition and results of operations

    2. Statement of significant related party transactions (as defined by the Audit Committee), submitted by management

    3. Management letters / letters of internal control weaknesses issued by the statutory auditors

    4. Internal audit reports relating to internal control weaknesses

    5. The appointment, removal and terms of remuneration of the chief internal auditor; and

    6. Statement of deviations in terms of the SEBI Listing Regulations

    a. quarterly statement of deviation(s) including report of monitoring agency, if applicable, submitted to stock exchange(s) where the Equity Shares are proposed to be listed in terms of the SEBI Listing Regulations; and

    b. annual statement of funds utilised for purposes other than those stated in the offer document/prospectus/notice in terms of the SEBI Listing Regulations.

    7. Review the financial statements, in particular, the investments made by any unlisted subsidiary

    8. Such information as may be prescribed under the Companies Act and the SEBI Listing Regulations

    Terms of Reference of Nomination and Remuneration Committee-

    1. Formulation of the criteria for determining qualifications, positive attributes and independence of a director and recommend to the Board, a policy relating to the remuneration of the directors, key managerial personnel and other employees;

    2. The Nomination and Remuneration Committee, while formulating the above policy, should ensure that:

    (i) the level and composition of remuneration be reasonable and sufficient to attract, retain and motivate directors of the quality required to run our Company successfully;

    (ii) relationship of remuneration to performance is clear and meets appropriate performance benchmarks; and

    (iii) remuneration to directors, key managerial personnel and senior management involves a balance between fixed and incentive pay reflecting short- and long-term performance objectives appropriate to the working of our Company and its goals.

    3. For every appointment of an independent director, evaluating the balance of skills, knowledge and experience on the Board and on the basis of such evaluation, preparing a description of the role and capabilities required of an independent director. The person recommended to the Board for appointment as an independent director shall have the capabilities identified in such description. For the purpose of identifying suitable candidates, the Nomination and Remuneration Committee may: (a) use the services of an external agencies, if required; (b) consider candidates from a wide range of backgrounds, having due regard to diversity; and (c) consider the time commitments of the candidates;

    4. Formulation of criteria for evaluation of independent directors and the Board;

    5. Devising a policy on Board diversity;

    6. Identifying persons who are qualified to become directors and who may be appointed in senior management in accordance with the criteria laid down, and recommend to the Board their appointment and removal and carrying out evaluation of every director’s performance (including independent director);

    7. Analysing, monitoring and reviewing various human resource and compensation matters;

    8. Deciding whether to extend or continue the term of appointment of the independent director, on the basis of the report of performance evaluation of independent directors;

    9. Determining our Company’s policy on specific remuneration packages for executive directors including pension rights and any compensation payment, and determining remuneration packages of such directors;

    10. Recommending to the board, all remuneration, in whatever form, payable to non-executive directors and the senior management and other staff, as deemed necessary;

    11. Carrying out any other functions required to be carried out by the Nomination and Remuneration Committee as contained in the SEBI Listing Regulations or any other applicable law, as and when amended from time to time;

    12. Reviewing and approving our Company’s compensation strategy from time to time in the context of the then current Indian market in accordance with applicable laws;

    13. Perform such functions as are required to be performed by the compensation committee under the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, if applicable

    14. Administering the employee stock option scheme/plan approved by the Board and shareholders of our Company in accordance with the terms of such scheme/plan (“ESOP Scheme”) including the following:

    i. Adopt rules and regulations for implementing the Plan from time to time;

    ii. Identify the Employees eligible to participate under the Plan;

    iii. Grant Options to the Eligible Employees, in one or more tranches, and determine the Grant Date;

    iv. Determine the quantum of the Options to be granted under the Plan per Eligible Employee and in aggregate;

    v. Determine the conditions under which Options vested would lapse for the Participant (in case of termination of employment for Cause);

    vi. Determine the Exercise Period within which the Participant should exercise the Option and the period within which the Option should lapse on the failure to exercise the Options within the Exercise Period;

    vii. Determine the specified time period within which the Participant shall exercise / surrender the Vested Options in the event of termination or resignation of the Participant;

    viii. Determine the right of a Participant to exercise all the Options vested in the Participant at one time or various points in time within the Exercise Period;

    ix. Determine the procedure for making a fair and reasonable adjustment to the number of Options and to the Exercise Price in case of Corporate Actions such as rights issues, bonus issues, merger, sale of division and others;

    x. Determine the Grant, Vesting and Exercise of Options in case of Participants who are on Long Leave;

    xi. amend or revise the vesting conditions, schedule, Exercise Period and / or Exercise Price for options granted or other terms and conditions of the Plan.

    xii. Determine the procedure for cash less exercise of Options, if decided by the Board;

    xiii. Decide to pay cash benefit / compensation to the Participant in lieu of the Options already granted to them, whether vested or not, and consequently surrender such respective options for which compensation is paid to the Participant;

    xiv. To create a trust to manage the Plan for all or any identified part of the options granted under the Plan, if needed

    xv. Take any other actions and make any other determinations or decisions that it deems necessary or appropriate in connection with the Plan or the administration or interpretation thereof

    xvi. Decide all other matters that must be determined in connection with an Option under the Plan;

    xvii. Construe and interpret the terms of the Plan, and the Options granted pursuant to the Plan and approve all forms and documents required to be issued to the Eligible Employees pursuant to the Plan;

    xviii. Administer and reconcile any inconsistency in the Plan; and

    xix. Perform such other functions and duties as shall be required under the Applicable Laws, including intimation, filing of documents/ application at the requisite authorities and listing of shares after exercise at Stock Exchanges.

    15. Construing and interpreting the employee stock option scheme/plan approved by the Board and shareholders of our Company in accordance with the terms of such scheme/plan and any agreements defining the rights and obligations of our Company and eligible employees under the ESOP scheme, and prescribing, amending and/or rescinding rules and regulations relating to the administration of the ESOP scheme;

    16. Frame suitable policies, procedures and systems to ensure that there is no violation of securities laws, as amended from time to time, including:

    (a) the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015; and

    (b) the Securities and Exchange Board of India (Prohibition of Fraudulent and Unfair Trade Practices Relating to the Securities Market) Regulations, 2003, by the trust, our Company and its employees, as applicable.

    17. Perform such other activities as may be delegated by the Board or specified/ provided under the Companies Act, 2013 to the extent notified and effective, as amended or by the SEBI Listing Regulations, as amended or by any other applicable law or regulatory authority.

    Terms of Reference of Stakeholders’ Relationship Committee-

    (1) Resolving the grievances of the security holders of our Company including complaints related to transfer of shares or debentures, including non-receipt of share or debenture certificates and review of cases for refusal of transfer / transmission of shares and debentures, non-receipt of annual report or balance sheet, non-receipt of declared dividends, issue of new/duplicate certificates, general meetings etc. and assisting with quarterly reporting of such complaints and formulating procedures in line with statutory guidelines to ensure speedy disposal of various requests received from shareholders;

    (2) Review of measures taken for effective exercise of voting rights by shareholders;

    (3) Investigating complaints relating to allotment of shares, approval of transfer or transmission of shares, debentures or any other securities;

    (4) Giving effect to all transfer/transmission of shares and debentures, dematerialisation of shares and rematerialisation of shares, split and issue of duplicate/consolidated share certificates, compliance with all the requirements related to shares, debentures and other securities from time to time;

    (5) Review of adherence to the service standards adopted by the listed entity in respect of various services being rendered by the registrar and share transfer agent of our Company and to recommend measures for overall improvement in the quality of investor services;

    (6) Review of the various measures and initiatives taken by our Company for reducing the quantum of unclaimed dividends and ensuring timely receipt of dividend warrants/annual reports/statutory notices by the Shareholders;

    (7) To approve allotment of shares, debentures or any other securities as per the authority conferred / to be conferred to the committee by the Board of Directors from time to time;

    (8) To approve requests for transfer, transposition, deletion, consolidation, sub-division, change of name, dematerialization, rematerialisation etc. of shares, debentures and other securities;

    (9) To monitor and expedite the status and process of dematerialization and rematerialisation of shares, debentures and other securities of our Company;

    (10) Carrying out such other functions as may be specified by the Board from time to time or specified/provided under the Companies Act or SEBI Listing Regulations, or by any other regulatory authority; and

    (11) Such terms of reference as may be prescribed under the Companies Act and SEBI Listing Regulations.

    Terms of Reference of Corporate Social Responsibility Committee-

    a) Formulate and recommend to the Board, a CSR Policy which shall indicate the activities to be undertaken by the Company as specified in Schedule VII to the Companies Act, 2013;

    b) Recommend the amount of expenditure to be incurred on the activities referred to in clause (a);

    c) Monitor the CSR policy of the Company from time to time;

    d) formulate and recommend to the Board, an annual action plan in pursuance of its CSR policy, which shall include the items as mentioned in rule 5(2) of the Companies (CSR Policy) Rules, 2014;

    e) shall recommend to the Board on budget allocation for any CSR project including modalities of utilisation of funds in every project; and

    f) such duties and responsibilities in accordance with Section 135 and the applicable rules, amended from time to time.

    g) To do such other acts, deeds and things as may be directed by the board and required to comply with the applicable laws.

 

 Contact Information

• Registrar & Transfer Agent

Bigshare Services Private Limited

Office No. S6-2, 6th Floor, Pinnacle Business Park, Next to Ahura Centre, Mahakali Caves Road, Andheri (East), Mumbai - 400 093, Maharashtra, India Tel.: + 91 22 6263 8200 Fax: +91 22 6263 8299

SEBI Regn. No.: INR000001385 Contact Person: Babu Raphael

E-mail ID: ipo@bigshareonline.com Website: www.bigshareonline.com

• Company Secretary & Compliance Officer & Grievance Redressal

Pinal Rakesh Darji

Unit 515, 5th Floor, C Wing, 1 MTR Cabin, Atrium, Village Mulgaon, MV Road, Andheri (East), Near Acme Plaza, Mumbai - 400 069, Maharashtra, India

Tel: +91 22 6211 0900 E-mail: cs@proventusagro.com

• Person Authorized for determination of materiality of event

Mr. Durga Prasad Jhawar (Managing Director and CEO) | email: dpjhawar@provfoods.com